Trial Profile
A Phase IA Open Label, Dose Escalation Study of BQS481 Administered Intravenously to Adult Patients with Advanced Solid Tumors (Novartis # CBQS481A2101)
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 20 Mar 2009
Price :
$35
*
At a glance
- Drugs BQS 481 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 30 Jan 2009 New trial record